Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 25 of 86 entries
View as:

An Open Label SLV308 Safety Extension to Study S308.3.002 in Patients With Parkinson's Disease Experiencing Motor Fluctuations.

Phase: N/A Priority: Normal
NCT ID: NCT00407095 Org: User:
Start: 08/31/07 End: 05/31/09 Due: 05/31/10

Study to Investigate ADME of 14C Labeled SLV334 After an i.v. Infusion

Phase: N/A Priority: Normal
NCT ID: NCT01044524 Org: User:
Start: 02/28/10 End: 03/31/10 Due: 03/31/11

Intravenous Tedisamil in the Rapid Conversion of Atrial Fibrillation or Flutter to Normal Sinus Rhythm in Male Subjects

Phase: N/A Priority: Normal
NCT ID: NCT00126061 Org: User:
Start: 10/31/04 End: 01/31/06 Due: 01/31/07

Dose-ranging Study to Evaluate Efficacy of SLV339 in Pancreatic Exocrine Insufficiency Due to Chronic Pancreatitis

Phase: N/A Priority: Normal
NCT ID: NCT00630279 Org: User:
Start: 02/29/08 End: 03/31/09 Due: 03/31/10

Immunogenicity and Safety of Two Adjuvant Formulations of an Egg-Derived Pandemic Vaccine

Phase: N/A Priority: Normal
NCT ID: NCT00562237 Org: User:
Start: 07/31/07 End: 09/30/08 Due: 09/30/09

Analgesic Effectiveness of Three Different Doses of a New Formulation of Lamaline in a Model of Painful Knee (Gonarthrosis)

Phase: N/A Priority: Normal
NCT ID: NCT00264225 Org: User:
Start: 12/31/05 End: - Due: -

Study to Evaluate Cardiac Hemodynamics and Safety of SLV320 in Subjects With Congestive Heart Failure

Phase: N/A Priority: Normal
NCT ID: NCT00160134 Org: User:
Start: 01/31/05 End: - Due: -

Safety and Efficacy of PROMETRIUM® Capsules in Induction of Secretory Conversion

Phase: N/A Priority: Normal
NCT ID: NCT00160199 Org: User:
Start: 11/30/04 End: 02/28/09 Due: 02/28/10

Acceptability Study of a New Fixed Combination of Fenofibrate 80 mg BID and Metformin 1000 mg BID in Type 2 Diabetes and Dyslipidemia

Phase: N/A Priority: Normal
NCT ID: NCT00490178 Org: User:
Start: 03/31/07 End: - Due: -

Fluvoxamine Maleate in the Treatment of Depression/Depressive State : A Post-marketing Clinical Study in Children and Adolescents

Phase: N/A Priority: Normal
NCT ID: NCT00353028 Org: User:
Start: 10/31/06 End: 07/31/09 Due: 07/31/10

An Open Label SLV308 Safety Extension to Study S308.3.003 in Early PD Patients

Phase: N/A Priority: Normal
NCT ID: NCT00335374 Org: User:
Start: 08/31/07 End: 11/30/08 Due: 11/30/09

Efficacy of Pancrelipase on Postprandial Belching and Bloating.

Phase: N/A Priority: Normal
NCT ID: NCT00266721 Org: User:
Start: 01/31/00 End: 10/31/00 Due: 10/31/01

Pharmacokinetic Evaluation of Testosterone Gel (1%)

Phase: N/A Priority: Normal
NCT ID: NCT00193700 Org: User:
Start: 08/31/02 End: - Due: -

Endometrial Safety Study of a 0.5 mg Estradiol and 2.5 mg Dydrogesterone Combination

Phase: N/A Priority: Normal
NCT ID: NCT00160316 Org: User:
Start: 04/30/05 End: 12/31/07 Due: 12/31/08

A Methodological Study To Evaluate The Effects of Single Oral Doses Of Pioglitazone 45 mg And Rosiglitazone 8 mg On Sodium Balance In Healthy Male Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT01088594 Org: User:
Start: 02/28/10 End: 03/31/10 Due: 03/31/11

A Multinational, Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study to Investigate the Efficacy, Safety and Duration of Effect of a Single Administration of Various Doses of Cetrorelix SR in Subjects With Histologically Confirmed Endometriosis

Phase: N/A Priority: Normal
NCT ID: NCT00244452 Org: User:
Start: 11/30/05 End: 09/30/06 Due: 09/30/07

Gastrectomy Study: Study to Investigate the Effect of Creon 25000 Minimicrospheres on Body Mass Index (BMI) in Patients After Gastrectomy

Phase: N/A Priority: Normal
NCT ID: NCT00160186 Org: User:
Start: 12/31/03 End: 05/31/06 Due: 05/31/07

A Randomized, Double-Blind Trial Comparing the Efficacy and Safety of Fenofibrate, Metformin, Their Combination and Placebo in Patients With Metabolic Syndrome.

Phase: N/A Priority: Normal
NCT ID: NCT00703755 Org: User:
Start: 03/31/03 End: 06/30/04 Due: 06/30/05

Dronabinol Versus Standard Ondansetron Antiemetic Therapy in Preventing Delayed-Onset Chemotherapy-Induced Nausea and Vomiting

Phase: N/A Priority: Normal
NCT ID: NCT00642512 Org: User:
Start: 07/31/03 End: 07/31/04 Due: 07/31/05

Progressively Decreasing Titration Schedules of Bifeprunox in Subjects With Schizophrenia or Bipolar Disorder

Phase: N/A Priority: Normal
NCT ID: NCT00139919 Org: User:
Start: 01/31/06 End: 10/31/07 Due: 10/31/08

Annual Study to Investigate Inactivated Subunit Influenza Vaccine for the 2006/2007 Influenza Season in Europe.

Phase: N/A Priority: Normal
NCT ID: NCT00346723 Org: User:
Start: 07/31/06 End: - Due: -

Patient-reported Outcomes in the Treatment of Schizophrenia

Phase: N/A Priority: Normal
NCT ID: NCT00230828 Org: User:
Start: 05/31/05 End: - Due: -

Compare the Effects of Bifeprunox and Quetiapine on Weight Changes in Stable Schizophrenic Patients

Phase: N/A Priority: Normal
NCT ID: NCT00396214 Org: User:
Start: 04/30/07 End: 01/31/08 Due: 01/31/09

Trial to Evaluate Effect of Lactulose on Hard Stools in Patients With Hemorrhoids or Anal Fissures

Phase: N/A Priority: Normal
NCT ID: NCT00160290 Org: User:
Start: 03/31/02 End: 06/30/06 Due: 06/30/07

SLV 308 and Pramipexole for Treatment of Patients With Early Parkinson Disease

Phase: N/A Priority: Normal
NCT ID: NCT00335166 Org: User:
Start: 11/30/06 End: 02/29/08 Due: 02/28/09